http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0563023-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
filingDate 1993-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a659b50f830266b2f8fee5bdaff24ea0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d025445b7e30ac888dd6f58a419210f
publicationDate 1993-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0563023-A1
titleOfInvention Use of tissue factor pathway inhibitor for the manufacture of a medicament for use in a method of inhibiting microvascular thrombosis
abstract The use is disclosed of tissue factor pathway inhibitor (TFPI) for the manufacture of a medicament for use in a method for reducing the thrombogenicity of microvascular anastomoses in a warm blooded mammal comprising administering to said mammal at the site of said microvascular anastomoses contemporaneously with microvascular reconstruction of a small but inhibitory effective amount of TFPI.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0791358-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0914830-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9601649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0791358-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0865291-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6025329-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0865291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9606637-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0914830-A1
priorityDate 1992-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9102753-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0473564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0318451-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0439442-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0300988-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9119514-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136326756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128241576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110

Total number of triples: 48.